David F. Archer

Reproductive Medicine
601 Colley Ave
Norfolk, VA 23507

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 187 publications

Authors' reply to L. Kiesel et al.

Authors' reply to L. Kiesel et al.

Journal: Maturitas
Published: July 15, 2026

Comparing the TCu380A and a small Nova-T copper IUD: secondary analysis of discontinuation probabilities, bleeding outcomes and satisfaction in nulliparous participants from a 3-year randomized trial.

Comparing the TCu380A and a small Nova-T copper IUD: secondary analysis of discontinuation probabilities, bleeding outcomes and satisfaction in nulliparous participants from a 3-year randomized trial.

Journal: Contraception
Published: March 08, 2026

Estrobolome: Is there a missing link?

Estrobolome: Is there a missing link?

Journal: The Journal of steroid biochemistry and molecular biology
Published: January 02, 2026

Estetrol (E4) for the treatment of moderate to severe vasomotor symptoms in postmenopausal women - Efficacy and safety results from the phase 3 E4COMFORT I multicenter, placebo-controlled study.

Estetrol (E4) for the treatment of moderate to severe vasomotor symptoms in postmenopausal women - Efficacy and safety results from the phase 3 E4COMFORT I multicenter, placebo-controlled study.

Journal: Maturitas
Published: December 19, 2025

Contraceptive Efficacy and Comparative Side Effects of a Mini Copper Intrauterine Device.

Contraceptive Efficacy and Comparative Side Effects of a Mini Copper Intrauterine Device.

Journal: NEJM evidence
Published: July 22, 2025

Comparison of estrogens and selective estrogen receptor modulators (SERMs) used for menopausal hormone therapy.

Comparison of estrogens and selective estrogen receptor modulators (SERMs) used for menopausal hormone therapy.

Journal: Menopause (New York, N.Y.)
Published: October 11, 2024

Double dosing ulipristal acetate emergency contraception for individuals with obesity: a randomised crossover trial.

Double dosing ulipristal acetate emergency contraception for individuals with obesity: a randomised crossover trial.

Journal: BMJ sexual & reproductive health
Published: May 19, 2024

Recommended measurement instruments for genitourinary symptoms associated with menopause: the COMMA (Core outcomes in menopause) consortium.

Recommended measurement instruments for genitourinary symptoms associated with menopause: the COMMA (Core outcomes in menopause) consortium.

Journal: Menopause (New York, N.Y.)
Published: May 14, 2024

Recommended measurement instruments for menopausal vasomotor symptoms: the COMMA (Core Outcomes in Menopause) consortium.

Recommended measurement instruments for menopausal vasomotor symptoms: the COMMA (Core Outcomes in Menopause) consortium.

Journal: Menopause (New York, N.Y.)
Published: April 30, 2024

Validation of an In Vitro Diagnostic Test for Endometriosis: Impact of Confounding Medical Conditions and Lesion Location.

Validation of an In Vitro Diagnostic Test for Endometriosis: Impact of Confounding Medical Conditions and Lesion Location.

Journal: International journal of molecular sciences
Published: April 17, 2024

Prostaglandin E2 regulates the plasminogen activator pathway in human endometrial endothelial cells: a new in vitro model to investigate heavy menstrual bleeding.

Prostaglandin E2 regulates the plasminogen activator pathway in human endometrial endothelial cells: a new in vitro model to investigate heavy menstrual bleeding.

Journal: F&S science
Published: March 06, 2024

Emergency contraception for individuals weighing 80 kg or greater: A randomized trial of 30 mg ulipristal acetate and 1.5 mg or 3.0 mg levonorgestrel.

Emergency contraception for individuals weighing 80 kg or greater: A randomized trial of 30 mg ulipristal acetate and 1.5 mg or 3.0 mg levonorgestrel.

Journal: Contraception
Published: January 09, 2024
Showing 1-12 of 187

Last Updated: 09/26/2026